Civil Complaint Courts Documents France Fraud Investment Listed Securities Regulatory United States District Court for the Southern District of New York USAMay 27, 2022

SEC v. Hugues Pierre Joublin: Complaint

Complaint alleging “insider trading by Joublin based on confidential information Joublin obtained while employed at AstraZeneca PLC” in U.S. Securities and Exchange Commission v. Hugues Pierre Joublin, described as a resident of France, at the U.S. District Court for the Southern District of New York.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 10

Date: May 27, 2022

Defendants/Respondents: Hugues Pierre Joublin

Plaintiffs/Applicants: Securities and Exchange Commission

Case Number: Xx Xx Xx

Topic: Investment, Listed Securities, Regulatory

Allegation: Fraud

Topics

USA

[ 1 more... ] [ top 5 ]

Keywords

AstraZeneca Daiichi Sankyo Hugues Pierre Joublin

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.